MULTIPLE MYELOMA

Latest News

Enhancing Outcomes in Myeloma With CAR T Cells and Bispecific Antibodies
Enhancing Outcomes in Myeloma With CAR T Cells and Bispecific Antibodies

March 18th 2024

March is Multiple Myeloma Awareness Month and experts like Amrita Krishnan, MD, and Adam D. Cohen, MD, explained the positive impact CAR T-cell therapies and bispecific antibodies have had in the space.

P-BCMA-ALLO1 Gains FDA Orphan Drug Designation in R/R Multiple Myeloma
P-BCMA-ALLO1 Gains FDA Orphan Drug Designation in R/R Multiple Myeloma

March 18th 2024

FDA’s ODAC Finds Cilta-Cel Favorable in R/R Multiple Myeloma
FDA’s ODAC Finds Cilta-Cel Favorable in R/R Multiple Myeloma

March 15th 2024

When CAR T Fails in Myeloma, Can Nivolumab Help?
When CAR T Fails in Myeloma, Can Nivolumab Help?

March 13th 2024

CAR T-Cell Therapy Targets GPRC5D in Multiple Myeloma
CAR T-Cell Therapy Targets GPRC5D in Multiple Myeloma

March 11th 2024

Video Series
Video Interviews
Podcasts

More News